Human galectin-3c in complex with a galactose derivative

Human galectin-3c in complex with a galactose derivative Descriptor: (2~{R},3~{R},4~{S},5~{R},6~{R})-2-(5-bromanylpyridin-3-yl)sulfanyl-6-(hydroxymethyl)-4-[4-[3,4,5-tris(fluoranyl)phenyl]-1,2,3-triazol-1-yl]oxane-3,5-diol, CHLORIDE ION, GLYCEROL, ... Authors: Zetterberg, F, Nilsson, U.J, Hakansson, M, Logan, D.T. Deposit date: 2022-05-03 Release date: 2022-11-02 Last modified: 2024-01-31 Method: X-RAY DIFFRACTION (1.05 Å) Cite: Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease. J.Med.Chem., 65, 2022